Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas
about
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivationFrizzled-7 dictates three-dimensional organization of colorectal cancer cell carcinoidsRadioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10Wnt/beta-catenin signaling and small molecule inhibitorsTargeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapyFrizzled homolog proteins, microRNAs and Wnt signaling in cancerSynovial sarcoma: recent discoveries as a roadmap to new avenues for therapyAFAP1L1, a novel associating partner with vinculin, modulates cellular morphology and motility, and promotes the progression of colorectal cancersSS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic ModifierElevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cells.Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma culturesMethylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer.Complex expression pattern of Wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes.Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis.The Wnt signaling pathway: implications for therapy in osteosarcoma.WNTS and WNT receptors as therapeutic tools and targets in human disease processes.Efficient construct of a large and functional scFv yeast display library derived from the ascites B cells of ovarian cancer patients by three-fragment transformation-associated recombination.The role of microarray technologies in the study of soft tissue tumours.Molecular target therapy for synovial sarcoma.Adult human sarcomas. I. Basic science.Adult human sarcomas. II. Medical oncology.Gene translocations in musculoskeletal neoplasms.Targeted therapies for soft-tissue sarcomas.Survival-related profile, pathways, and transcription factors in ovarian cancerInhibition of canonical WNT/β-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells.3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma.Gene expression profiles of human liver cells mediated by hepatitis B virus X proteinWNT signaling in glioblastoma and therapeutic opportunities.BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10.Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy.'WNT-er is coming': WNT signalling in chronic lung diseases.Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.Non-canonical WNT/PCP signalling in cancer: Fzd6 takes centre stage.Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis.Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling.Cell-type specific potent Wnt signaling blockade by bispecific antibody.Frizzled-10 and cancer progression: Is it a new prognostic marker?Wnt signaling in cervical cancer?
P2860
Q21195230-126C8325-9A84-4D3C-B4CF-0E869F165BBBQ24305464-62F3F416-1E1A-462D-A8FD-940198507AB5Q24313293-38824341-B205-42B9-AF1B-A6796C1E8955Q24597197-7BE875BF-89A8-4F54-9700-ADA080FCC60CQ26775961-2E3F7E8E-A1C3-4D12-9ACF-64099D385AACQ27010132-A2C21672-8E24-45A4-AAC4-FDF9C54EEE10Q28087134-269AAC20-C346-455F-BD8E-75A0CFF1C07CQ28386237-3C09A288-FCEB-47D1-AA01-0978B29A79CCQ28550973-C7FF6F50-23F9-4B1C-8302-80D53B9FB05AQ33269602-1CA65B29-975E-4A76-BE55-971A6854FEDAQ33278631-FF890E48-43B3-4927-A8DC-DAF38B22B9B6Q33380436-BD99A519-7E12-4B76-8B39-055535285FD3Q33827681-548E931E-6FF2-4C86-9ACE-B1CC8C0933C6Q34235433-6464233E-C622-4CC3-A38E-50C42143FD58Q34621899-879FCFAA-80AB-4941-B2C1-1726430BF40CQ34632285-71530CAC-6DF0-4F46-BF3C-E1383AFE4D2DQ35093167-5125DC97-9727-41B5-875C-1C156908AA9BQ35897306-9C5F7E13-B73F-456A-AFE3-14D6F5A7B164Q36344271-9448FA36-4C14-4B40-A8BE-7FEAEFA10320Q36429636-326875DB-0050-42DC-99C6-4FD9FB890D53Q36691805-6180994F-72E0-4CA8-9CAC-7AC7CD0687FEQ36731430-730B8D5C-C896-4417-A172-4B7C6A51AF51Q36803632-9C989A47-55A9-4A83-B968-69155D071BAFQ36817135-7B6B51E2-A3DC-4AD8-A057-E59108010BD2Q37081275-59990642-B762-490D-9BC8-1E43806F07BBQ37580399-D053226C-7CFD-421A-9A86-72BF3F0C975BQ37590988-494E5EEE-15D0-4E63-BF20-76F3D974EF3FQ37727964-B80C6A19-C240-4891-8B25-5988B09B2335Q38660744-C5709BE3-9799-4488-94FF-2D529B5EE72FQ38939530-8871CD30-5152-48F6-8615-36B12FBD644EQ39233440-010EBBB2-E580-4E93-B813-A9C0405BCBD7Q39247047-D3187BDE-BAD4-47BA-96CF-FE99A950E763Q39400127-C0B8BF0F-DCA2-423F-8C74-98D2C9C5BA85Q39433833-AABE8D9D-FF90-4C7B-AB21-10AE3E8A38B4Q39454318-A892BBE8-B220-4ABF-A8EF-4C33E3606818Q40066000-2FE34D20-3F40-4203-B18A-02A915C054A5Q42912698-079D50DC-E844-496D-9814-B697B1823356Q49292906-8658619D-6AE2-4D55-9E4E-9307A9693ECDQ49343572-1E73B9CE-9706-4616-BE25-B56BBD581D42Q55017017-E0AA5FEA-D1A0-43F6-AA15-4FB3ABF6A59F
P2860
Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Therapeutic potential of antib ...... protein, for synovial sarcomas
@ast
Therapeutic potential of antib ...... protein, for synovial sarcomas
@en
Therapeutic potential of antib ...... protein, for synovial sarcomas
@en-gb
Therapeutic potential of antib ...... protein, for synovial sarcomas
@nl
type
label
Therapeutic potential of antib ...... protein, for synovial sarcomas
@ast
Therapeutic potential of antib ...... protein, for synovial sarcomas
@en
Therapeutic potential of antib ...... protein, for synovial sarcomas
@en-gb
Therapeutic potential of antib ...... protein, for synovial sarcomas
@nl
prefLabel
Therapeutic potential of antib ...... protein, for synovial sarcomas
@ast
Therapeutic potential of antib ...... protein, for synovial sarcomas
@en
Therapeutic potential of antib ...... protein, for synovial sarcomas
@en-gb
Therapeutic potential of antib ...... protein, for synovial sarcomas
@nl
P2093
P2860
P3181
P356
P1433
P1476
Therapeutic potential of antib ...... protein, for synovial sarcomas
@en
P2093
Chikako Fukukawa
Junya Toguchida
Masayuki Imamura
Naoki Oyaizu
Satoshi Nagayama
Takeshi Okamoto
Tomoki Aoyama
Toyomasa Katagiri
Yusuke Nakamura
P2860
P2888
P304
P3181
P356
10.1038/SJ.ONC.1208780
P407
P577
2005-09-15T00:00:00Z
P5875
P6179
1036794524